Woodline Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-123,750
| Closed | -$16.3M | – | 1090 |
|
|
2025
Q1 | $16.3M | Buy |
+123,750
| New | +$15.4M | 0.11% | 262 |
|
|
2023
Q4 | – | Sell |
-1,193,732
| Closed | -$62.2M | – | 689 |
|
|
2023
Q3 | $62.2M | Buy |
1,193,732
+1,001,176
| +520% | +$58.3M | 0.73% | 30 |
|
|
2023
Q2 | $12.2M | Buy |
+192,556
| New | +$12M | 0.14% | 183 |
|
|
2023
Q1 | – | Sell |
-392,030
| Closed | -$20.7M | – | 807 |
|
|
2022
Q4 | $20.7M | Buy |
392,030
+103,704
| +36% | +$5.2M | 0.28% | 100 |
|
|
2022
Q3 | $13.4M | Buy |
288,326
+160,984
| +126% | +$8.41M | 0.19% | 157 |
|
|
2022
Q2 | $7.27M | Buy |
+127,342
| New | +$7.22M | 0.11% | 213 |
|
|
2021
Q2 | – | Sell |
-294,285
| Closed | -$9.98M | – | 636 |
|
|
2021
Q1 | $9.98M | Sell |
294,285
-30,482
| -9% | -$1.06M | 0.22% | 118 |
|
|
2020
Q4 | $10.3M | Buy |
+324,767
| New | +$8.54M | 0.27% | 113 |
|
Other funds holding ITCI
KIM
HNB